Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
National Institute For Locomotor Disabilities
Bid Publish Date
04-Jun-2025, 10:56 am
Bid End Date
19-Jun-2025, 11:00 am
EMD
₹1,37,500
Progress
Quantity
209190
Bid Type
Two Packet Bid
Public procurement opportunity for Hfws Haveri Title1, Title2, Title3, Title4, Title5, Title6, Title7, Title8, Title9, Title10, Title11, Title12, Title13, Title14, Title15, Title16, Title17, Title18, Title19, Title20, Title21, Title22, Title23, Title24, Title25, Title26, Title27, Title28, Title29, Title30, Title31, Title32, Title33, Title34, Title35, Title36, Title37, Title38, Title39. Quantity: 209190 issued by. Submission Deadline: 19-06-2025 11: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
National Institute For Locomotor Disabilities
Central Coalfields Limited
HAZARIBAG, JHARKHAND
Central Reserve Police Force (crpf)
IMPHAL WEST, MANIPUR
Central Public Works Department (cpwd)
HYDERABAD, TELANGANA
Central Reserve Police Force (crpf)
IMPHAL WEST, MANIPUR
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | Ceftriaxone injection 1gm IP/BP/USP 1X1 Vial | 16,000 | 1x1 | mshaver2 | 20 |
| 2 | Title2 | Diclofenac injection 25mg/ml | 15,000 | 1x3ml | mshaver2 | 20 |
| 3 | Title3 | Pantoprazole injection 40mg | 17,000 | 1x1 vial | mshaver2 | 20 |
| 4 | Title4 | Hydrocortisone Sodium Succinate Injection 100mg | 2,000 | 1x1 vial | mshaver2 | 20 |
| 5 | Title5 | Iron Sucrose Injection 100mg/5ml | 1,200 | 1x1 | mshaver2 | 20 |
| 6 | Title6 | Piperacillin+Tazobactam Powder for injection. 4g+500mg | 1,600 | 1x1vial | mshaver2 | 20 |
| 7 | Title7 | Ceftriaxone with Sulbactum Injection 1gm+500mg | 1,600 | 1x1 | mshaver2 | 20 |
| 8 | Title8 | Amoxicillin+Clavulinic acid injection 1.2gm | 600 | 1x1vial | mshaver2 | 20 |
| 9 | Title9 | Paracetamol Infusion 1gm/100ml | 5,000 | 1x100ml | mshaver2 | 20 |
| 10 | Title10 | Merophenam 1G Inj | 200 | 1x1 | mshaver2 | 20 |
| 11 | Title11 | NS 100ML 1X1 | 4,000 | 1x1 | mshaver2 | 20 |
| 12 | Title12 | ANAWIN HAEVY INJ | 300 | 1x1 | mshaver2 | 20 |
| 13 | Title13 | NOR ADRENALINE INJ | 100 | 1x1 | mshaver2 | 20 |
| 14 | Title14 | INJ GENTAMYCIN AMP | 1,000 | 1x1 | mshaver2 | 20 |
| 15 | Title15 | LIGNOCAINE 2% 30ML VAIL | 60 | 1x1 | mshaver2 | 20 |
| 16 | Title16 | Sterile disposable syringe with hypodermic needle 2ml-23G | 30,000 | 1x1 | mshaver2 | 20 |
| 17 | Title17 | Sterile disposable syringe with hypodermic needle 5ml-23G | 30,000 | 1x1 | mshaver2 | 20 |
| 18 | Title18 | Sterile disposable syringe with hypodermic needle 10ml-23G | 10,000 | 1x1 | mshaver2 | 20 |
| 19 | Title19 | Sterile disposable IV Cannula with inj. Port 18G | 15,000 | 1x1 | mshaver2 | 20 |
| 20 | Title20 | Sterile disposable IV Cannula with inj. Port 20G | 15,000 | 1x1 | mshaver2 | 20 |
| 21 | Title21 | Sterile disposable IV Cannula with inj. Port 22G | 20,000 | 1x1 | mshaver2 | 20 |
| 22 | Title22 | Sterile disposable IV Cannula with inj. Port 24G | 12,000 | 1x1 | mshaver2 | 20 |
| 23 | Title23 | Bandage cloth individually packed20mtrs | 600 | 1x1 | mshaver2 | 20 |
| 24 | Title24 | Sterile surgical glove latex 6. | 5,000 | 1x1 | mshaver2 | 20 |
| 25 | Title25 | Urine collection bag with valve outlet | 300 | 1x1 | mshaver2 | 20 |
| 26 | Title26 | Spinal needle (lumber puncture) 24G | 400 | 1x1 | mshaver2 | 20 |
| 27 | Title27 | Spinal needle (lumber puncture) 25G | 400 | 1x1 | mshaver2 | 20 |
| 28 | Title28 | Spinal needle (lumber puncture) 26G | 200 | 1x1 | mshaver2 | 20 |
| 29 | Title29 | Adult diaper 1x10 | 400 | 1x1 | mshaver2 | 20 |
| 30 | Title30 | Elastic adhesive bandage(dynaplaster) | 60 | 1x1 | mshaver2 | 20 |
| 31 | Title31 | NEBULIZER MASK ADULT | 120 | 1x1 | mshaver2 | 20 |
| 32 | Title32 | Hypochloride solution 5ltr | 1,000 | 1x1 | mshaver2 | 20 |
| 33 | Title33 | Oxygen mask (A) | 1,200 | 1x1 | mshaver2 | 20 |
| 34 | Title34 | N-95 | 1,000 | 1x1 | mshaver2 | 20 |
| 35 | Title35 | Oxygen mask (P) | 100 | 1x1 | mshaver2 | 20 |
| 36 | Title36 | NEBULIZER MASK pead | 240 | 1x1 | mshaver2 | 20 |
| 37 | Title37 | Silverex oint 15GM | 100 | 1x1 | mshaver2 | 20 |
| 38 | Title38 | Glutaraldehyde 2% 5ltr | 10 | 1x1 | mshaver2 | 20 |
| 39 | Title39 | Underpad | 400 | 1x1 | mshaver2 | 20 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
Additional Doc 1 (Requested in ATC)
Additional Doc 2 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
The eligibility requirements include being a registered entity capable of supplying the required surgical and injection products. Bidders must ensure compliance with local and national regulations and are encouraged to be Micro, Small, and Medium Enterprises (MSEs).
Bidders need to provide product certifications that demonstrate compliance with the applicable quality standards and safety regulations. This includes any necessary licenses to operate within the healthcare sector.
To participate, businesses must register on the designated electronic tender submission portal. This includes providing necessary company information, financial details, and any documentation required to meet the qualification requirements.
Bidders must provide a financial proposal detailing costs and pricing strategies. The evaluation will consider payment terms and price evaluation considerations, where cost-effectiveness coupled with quality will be the focus.
Yes, the tender has special provisions for Micro, Small, and Medium Enterprises. This includes potential advantages in evaluation scoring and a more accessible qualification process, thereby fostering local participation and manufacturing.
By ensuring clarity and accessibility, this content covers essential information about the tender while adhering to SEO best practices, ensuring it gains visibility and reaches the appropriate audience effectively.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS